Electronic Cigarettes and Cardiovascular Risk: Science, Policy and the Cost of Certainty
Saved in:
Main Authors: | Olusola A Orimoloye, Albert D Osei, SM Iftekhar Uddin, Mohammadhassan Mirbolouk, Michael J Blaha |
---|---|
Format: | article |
Language: | EN |
Published: |
Radcliffe Medical Media
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/6b14f6740d964e1393c6c6d38ae15fc9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Electronic Cigarettes and Cardiovascular Risk: Caution Waiting for Evidence
by: Domenico D’Amario, et al.
Published: (2019) -
ASPIRIN FOR CARDIOVASCULAR DISEASE PREVENTION AMONG ADULTS IN THE UNITED STATES: TRENDS, PREVALENCE, AND PARTICIPANT CHARACTERISTICS ASSOCIATED WITH USE
by: Ellen Boakye, et al.
Published: (2021) -
Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science
by: Charles Amir German, et al.
Published: (2020) -
Cardiovascular Imaging and Theranostics in Cardiovascular Pharmacotherapy
by: Mattia Cattaneo, et al.
Published: (2019) -
Cardiovascular Pharmacotherapy Focus
by: Pablo Avanzas
Published: (2019)